Significance of α-fetoprotein in the development of novel therapeutic agents

Drugs of the Future

Volumn 24, Issue 1, 1999, Pages 55-65

  Wang, Xing Wang ^a   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; MESSENGER RNA; MONOCLONAL ANTIBODY; PROSTAGLANDIN J2; SCATTER FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTHRITIS; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; DEMYELINATING DISEASE; GROWTH REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION; TUMOR GROWTH;

EID: 0032997781     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.01.858616     Document Type: Review

References (80)

1. Wang, X.W., Xu, B. α-Fetoprotein, liver cancer and antitumor drugs. In: New Theories and New Techniques of Oncology. Cai, S.R. (Ed.). Shanghai Science and Technology Education Press: Shanghai 1997, 490-501.
2. Bergstrand, C.G., Czar, B. Paper electrophoretic study of human fetal serum proteins with demonstrations of a new protein fraction. Scand J Clin Lab Invest 1957, 9: 277-80.
3. Abelev, G.I., Perova, S.D., Khramkova, N.I., Postnikova, E.A., Irlin, I.S. Production of embryonal α-globulin by transplantable mouse hepatoma. Transplant Bull 1963, 1: 174-7.
4. Tatarinov, Y.S. Fetal α-globulin in the sera of patients with primary liver tumors. 1st Int Biochem Congress (Moscow) 1964, 2: 274 (Abst).
5. Uriel, J., de Nechaud, B., Dupiers. M. Estrogen-binding properties of rat, mouse and man fetospecific serum proteins: Demonstration by immunoautoradiographic methods. Biochem Biophys Res Commun 1972, 46: 1175-9.
6. Kim, E.E., Deland, F.H., Nelson, M.O. et al. Radioimmunodetection of cancer with radiolabeled antibodies to α-fetoprotein. Cancer Res 1980, 40: 3008-12.
7. Koji, T., Ishu, N., Munchisa, T. et al. Localization of radioiodinated antibody to α-fetoprotein in hepatoma transplanted in rats and a case report of AFP antibody treatment of a hepatoma patient. Cancer Res 1980, 40: 3013-5.
8. Tsukada, Y., Bischof, W.K.D., Hibi, N., Hirai, H., Hurwitz, E., Sela, M. Effect of a conjugate of daunomycin and antibodies to rat AFP in the growth of AFP-producing tumor cells. Proc Natl Acad Sci USA 1982, 79: 621-5.
9. Wang, X.W., Xu, B. Progress of studies on α-fetoprotein gene expression and regulation of the expression. Chin Oncol 1996, 6: 281-4.
10. Zhang, X.K., Dong, J.M.,Chiu, J.F. Regulation of α-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J Biol Chem 1991, 266: 8248-54.
11. Rabek, J.P., Zhang, D.E., Torres-Ramos, C.A., Papacoustantinou, J. Analysis of the mechanism of glucocorticoid-mediated downregulation of the mouse α-fetoprotein gene. Biochem Biophys Acta 1994, 1218: 136-44.
12. Nuñez, E.A. Biological role of ̃-fetoprotein in the endocrinological field: Data and hypotheses. Tumor Biol 1994, 15: 63-72.
13. Tamaoki, T., Morinaga, T., Sakai, M., Protheroe, G., Urano, Y. Structural analysis of the human α-fetoprotein gene. Ann NY Acad Sci 1983,417: 13-9.
14. Morinaga, T., Sakai, M., Wegman, T.G., Tamaoki, T. Primary structures of human α-fetoprotein and its mRNA. Proc Natl Acad Sci USA 1983, 80: 4604-8.
15. Luft, A.J., Lorscheider, F.L. Structural analysis of human and bovine α-fetoprotein by electron microscopy, image processing, and circular dichroism. Biochemistry 1983, 22: 5978-83.
16. Yamashita, K., Hitoi, A., Tsuchida, Y., Nishi, S., Kobeta, A. Sugar chain of α-fetoprotein produced in human yolk sac tumor. Cancer Res 1983, 43: 4691-8.
17. Jalanko, H., Engvall, E., Ruoslahti, E. Immunochemical properties of α-fetoprotein (AFP) and antibodies to autologous AFP. Immunol Commun 1978, 7: 209-16.
18. Ruoslahti, E., Engvall, E. Immunological cross-reaction between α-fetoprotein and albumin. Proc Natl Acad Sci USA 1976, 73: 4641-4.
19. Deutsch, H.F. Chemistry and biology of α-fetoprotein. Adv Cancer Res 1991, 56: 253-311.
20. Olinescu, A., Laky, M., Popescu, D.E., Dumitrescu, A., Ganea, D. The effect of α-fetoprotein on the immune response. III. Diminution of the phagocytosis capacity of macrophages cultured in vitro in the presence of mouse amniotic fluid or α-fetoprotein. Scand J Immunol 1978, 8: 397-401.
21. Hu, S.Z., Din, C.R., Zhong, J.L. et al. Effect of α-fetoprotein on macrophage. Acta Biochem Biophys Sin 1979, 11: 265-75.
22. Wang, X.W., Xu, B. Effect of α-fetoprotein on splenocyte proliferation of mice bearing ascites hepatoma-22 in vitro. Shanghai J Immunol 1995, 15: 327-9.
23. Murgita, R.A., Andersson, L.C., Sherman, M.S., Bennich, H., Wigzell, H. Effects of human α-fetoprotein on human B and T lymphocyte proliferation in vitro. Clin Exp Immunol 1978, 33: 347-56.
24. Wang, X.W., Xu, B. Effect of α-fetoprotein on immune functions of mice bearing ascites hepatoma-22 in vitro. Shanghai J Immunol 1997, 17: 224-6.
25. Hooper, D.C., Pagida, E., Murgita, R.A. Suppression of primary and secondary autologous mixed lymphocyte reactions by murine α-fetoprotein. Oncodev Biol Med 1982, 3: 151-9.
26. Gupta, S., Siegal, F.P. In vitro inhibition of E rosettes by human amniotic fluid. New Engl J Med 1975, 293: 302-12.
27. Cardoso, E., Valdez, G., Comini, E., Matera, L. Effect of human α-fetoprotein on native and in vitro-stimulated NK activity. J Clin Lab Immunol 1991, 34: 183-8.
28. Peck, A.B., Murgita, R.A., Wigzell, H. Cellular and genetic restrictions in the immunoregulatory activity of α-fetoprotein. II. Alpha-fetoprotein-induced suppression of cytotoxic T lymphocyte development. J Exp Med 1978, 147: 360-73.
29. Murgita, R.A., Tomasi, T.B. Suppression of the immune response by α-fetoprotein. I. The effect of mouse α-fetoprotein on the primary and secondary antibody response. J Exp Med 1975, 141: 269-86.
30. Murgita, R.A., Tomasi, T.B. Suppression of the immune response by α-fetoprotein. II. The effect of mouse alpha-fetoprotein on mixed lymphocyte reactivity and mitogen induced lymphocyte transformation. J Exp Med 1975, 141: 440-52.
31. Orga, S.S., Murgita, R., Tomasi, T.B. Immunosuppressive activity of mouse amniotic fluid. Immunol Commun 1974, 3: 497-508.
32. Murgita, R.A., Goidel, E.A., Kontiainen, S., Wigzell, H. α-Fetoprotein induces suppressor T cells in vitro. Nature 1977, 267: 257-9.
33. Toder, V., Blank, M., Gleicher, N., Nebel, L. Immunoregulatory mechanisms in pregnancy. II. Further characterization of suppressor lymphocytes induced by α-fetoprotein in lymphoid cell cultures. J Clin Lab Immunol 1983, 11: 149-54.
34. Wang, X.W., Xu, B. Anti-α-fetoprotein activity of L-4-oxalysine. Asia Pacific J Pharmacol 1996, 11: 25-8.
35. Lu, C.Y., Changelian, P.S., Unanue, E.R. α-Fetoprotein inhibits macrophage expression of la antigens. J Immunol 1984, 132: 1722-7.
36. Laan-Putsep, K., Wigzell, H., Cotran, P., Gidlund, M. Human α-fetoprotein causes down-regulation of monocyte MHC class II molecules without altering other induced or noninduced monocyte markers or functions in monocytoid cell lines. Cell Immunol 1991, 133: 506-19.
37. Wang, W., Alpert, E. Downregulation of phorbol-12-myristate 13-acetate-induced tumor necrosis factor-α and interleukin-1beta production and gene expression in human monocytic cells by human α-fetoprotein. Hepatology 1995, 22: 921-8.
38. Lang, A.K., Searle, R.F. The immunomodutatory activity of human amniotic fluid can be correlated with transforming growth factor-β1 (TGF-β1) and -β2 activity. Clin Exp Immunol 1994, 97: 158-63.
39. Yamashita, T., Nakane, A., Watanabe, T., Miyoshi, I., Kasai, N. Evidence that α-fetoprotein suppresses the immunological function in transgenic mice. Biochem Biophys Res Commun 1994, 201: 1154-9.
40. Suzuki, Y., Zeng, C.Q., Alpert, E. Isolation and partial characterization of a specific α-fetoprotein receptor on human monocytes. J Clin Invest 1992, 90: 1530-6.
41. Dattwyler, R.J., Murgita, R.A., Tomasi, T.B. Binding of α-fetoprotein to murine T cells. Nature 1975, 256: 656-7.
42. Wang, X.W., Xu, B. Influence of α-fetoprotein on the growth of tumor cells in vitro. Chin J Cancer Res 1997, 9: 79-82.
43. Wang, Y.L., Yang, G.H., He, K.Y., Wang, G.H. The effect of human α-fetoprotein on the RNA synthesis of mouse ascites hepatoma cells in vitro. Chin J Clin Oncol 1989, 16: 290-3.
44. Leal, J.A., Gangrede, B.K., Kiser, J.L., May, J.V., Keel, B.A. Human mammary tumor cell proliferation: Primary role of platelet-derived growth factor and possible synergism with human α-fetoprotein. Steroids 1991, 56: 247-51.
45. Mizejewski, G.J., Yong, S.R., Allen, R.P. α-Fetoprotein: Effect of heterologous antiserum on hepatoma cells in vitro. J Natl Cancer Inst 1975, 54: 1361-5.
46. Villacampa, M.J., Moro, R., Naval, J., Failly-Crepin, C., Lampreave, F., Uriel, J. α-Fetoprotein receptors in a human breast cancer cell line. Biochem Biophys Res Commun 1984, 122: 1322-7.
47. Loferoute, M.P., Pilarski, L.M. The inhibition of apoptosis by AFP and the role of AFP receptors in anti-cellular senescence. Anticancer Res 1994, 14: 2429-38.
48. Gershwin, M.E., Castles, J.J., Makishima, R. Accelerated plasmacytoma formation in mice treated with α-fetoprotein. J Natl Cancer Invest 1980, 64: 145-9.
49. Yamada, A., Hayami, M. Suppression of natural killer cell activity by chicken α-fetoprotein in Japanese quails. J Natl Cancer Invest 1983, 70: 735-8.
50. Gershwin, M.E., Castles, J.J., Ahmed, A., Makishima, R. The influence of α-fetoprotein on Moloney sarcoma virus oncogenesis: Evidence for generation of antigen nonspecific suppressor T cells. J Immunol 1978, 121: 2292-8.
51. Keel, B.A, Eddy, R.B., Cho, S., May, J.V. Synergistic action of purified α-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture. Endocrinology 1991, 129:217-25.
52. Toran-Allerand, C.D. Regional differences in intraneurone localization of α-fetoprotein in developing mouse brain. Dev Brain Res 1982, 5: 213-7.
53. Toder, V., Bland, M., Gold-Geffer, L., Nebel, J. The effect of α-fetoprotein on the growth of placental cells in vitro. Placenta 1983, 4: 79-86.
54. Seppala, M. Fetal pathophysiology of human α-fetoprotein. Ann NY Acad Sci 1975, 259: 59-73.
55. Wang, X.W., Xu, B. Several new targets of antitumor agents. Acta Pharmacol Sin 1997, 18: 289-92.
56. Ogata, A., Yamashita, T., Koyama, Y., Sakai, M., Nishi, S. Suppression of experimental antigen-induced arthritis in transgenic mice producing human α-fetoprotein. Biochem Biophys Res Commun 1995, 213: 362-6.
57. Abramsky, O., Brenner, T., Mizrachi, R., Soffer, D. α-Fetoprotein suppresses experimental allergic encephalomyelitis. J Neuroimmunol 1982, 2: 1-7.
58. Gershwin, M.E., Castles, J.J., Makishima, R. α-Fetoprotein-associated alteration of a New Zealand mouse immunopathology. Immunopharmacolology 1979, 1: 331-41.
59. Zakarija, M., Mckenzie, J.M. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983, 57: 1036-46.
60. Kaneko, S., Hallenbeck, P., Kotani, T. et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995, 55: 5283-7.
61. Wang, X.W., Xu, B. Drug susceptibility genes and chemotherapy of tumors. Chin J Clin Oncol 1996, 23: 663-6.
62. 2 on cell proliferation and α-fetoprotein expression in HuH-7 human hepatoma cells. Prostaglandins 1992, 43: 189-97.
63. 1 differentially regulates α-fetoprotein and albumin in human hepatoma cells. Biochem Biophys Res Commun 1991, 174: 1294-302.
64. Xu, W.M., Li, S.K., Wang, Y.L., Zhao, Z.L., Wang, G.H., Su, C.Z. Antigen-specific transfer factor antagonizes the promotive effect of human α-fetoprotein on RNA synthesis in mouse hepatoma-22 ascites cells. Chin J Clin Oncol 1993, 20: 897-900.
65. Xu, W.M., Zhu, L.G., Cai, Y.B., Ji. M., Wang, Y.L., Su, D.Z. Antigen-specific transfer factor antagonizes the suppressive effect of human α-fetoprotein on protein synthesis in mouse lymphocytes. Shanghai J Immunol 1991, 11: 336-8.
66. Hatano, M., Nakata, K., Nakao, K. et al. Hepatocyte growth factor down-regulates the α-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells. Biochem Biophys Res Commun 1992, 189: 385-91.
67. Liu, Z., Liu, G., Zhang, S. Reversing effect of dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2, 2′-dicarboxylate (DDB) on the phenotypes of human hepatocarcinoma cell line. Chin J Med 1995, 25: 676-8.
68. Wang, X.W., Xu, B. L-4-Oxalysine, a new antitumor agent of natural origin. Med Chem Res 1996, 6: 225-32.
69. Wang, X.W., Xu, B. Mechanisms of antitumor action of L-4-oxalysine, a new natural product. Med Chem Res 1996, 6: 233-47.
70. Wang, X.W., Xu, B. Effect of L-4-oxalysine on α-fetoprotein gene expression in human BEL-7404 hepatoma cells. Asia Pacific J Pharmacol 1997, 12: 65-8.
71. Wang, X.W., Xu, B. Expression of α-fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effects of L-4-oxalysine on the expression. World J Gastroenterol 1998, 4: 294-7.
72. Wang, X.W., Xu, B. Informal drugs and gene therapy of human diseases. Chin Pharmacol Bull 1996, 12: 289-92.
73. Wang, X.W., Xu, B. Ribozymes and application in tumor therapy. J Clin Oncol (China) 1996, 1: 65-6.
74. Wang, X.W., Xu, B. Immunostimulatory action of L-4-oxalysine counteracts immunosuppression induced by α-fetoprotein. Eur J Pharmacol 1998, 351: 105-11.
75. Wang, X.W., Xu, B. Stimulation of tumor-cell growth by α-fetoprotein. Int J Cancer 1998, 75: 596-9.
76. Wang, X.W., Xie, H. α-Fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 1999, 64: 17-23.
77. Wang, X.W., Xie, H. Growth inhibition of human liver cancer cells by α-fetoprotein antisense strategy In Vitro Cell Dev Biol 1999, in press.
78. Wang, X.W., Xie, H. Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells. World J Gastroenterol 1998, 4: 540-3.
79. Wang, X.W., Xie, H. Further strengthening of α-fetoprotein studies. Nat Med J Chin 1998, 78: 723-4.
80. Wang, X.W., Xie, H. α-Fetoprotein and liver cancer biotherapy. Chin J Cancer Biother 1998, 5: 235.